Loading...
By Amy Orciari Herman
The potential risk for cancer dissemination associated with uterine morcellation has again come under scrutiny, this time in two articles in JAMA.
A news perspective piece describes the issue: When fibroids or uterine tissue is cut into small pieces during morcellation, there's a risk that undetected malignant cells could spread into the abdominal cavity. In one study, two of seven patients with undiagnosed stage I uterine leiomyosarcoma and one of four with undiagnosed stage I smooth muscle tumors had disseminated intraperitoneal disease after morcellation.
"The problem is that, in most cases, we don't have a perfectly reliable way to identify patients with uterine sarcoma in the preoperative setting," said one expert.
The authors of a separate article contend that the limited experience with morcellation doesn't allow estimates of "whether the benefit-to-harm balance is any different from other accepted medical procedures."
Both articles note that lower-risk, experimental morcellation techniques are promising.
Comment
LINK(S):
JAMA Medical News & Perspectives (Free)
JAMA Viewpoint (Free)
Background: Physician's First Watch previous coverage of uterine morcellation and cancer (Free)